Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers
Journal
Proceedings of the National Academy of Sciences of the United States of America
Publication Date
4-4-2023
Volume
120
Issue
14
First Page
e2220413120
Document Type
Open Access Publication
DOI
10.1073/pnas.2220413120
Rights and Permissions
Rao Y, Samuels Z, Carter LM, Monette S, Panikar SS, Pereira PMR, Lewis JS. Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers. Proc Natl Acad Sci U S A. 2023 Apr 4;120(14):e2220413120. doi: 10.1073/pnas.2220413120. This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).
Recommended Citation
Rao, Yi; Samuels, Zachary; Carter, Lukas M; Monette, Sebastien; Panikar, Sandeep Surendra; Pereira, Patricia M R; and Lewis, Jason S, "Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers." Proceedings of the National Academy of Sciences of the United States of America. 120, 14. e2220413120 (2023).
https://digitalcommons.wustl.edu/oa_4/2033
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
